Business Context and Reporting Period
This Form 6-K filing by Compugen Ltd. covers the month of April 2020, specifically reporting on a corporate transaction completed on April 14, 2020. The Company is a foreign private issuer headquartered in Holon, Israel.
Key Financial Metrics
The filing details a capital raise event rather than operational financial performance. Key figures include:
- Additional Shares Issued: 483,005 ordinary shares sold pursuant to an underwriters' option.
- Gross Proceeds from Additional Sale: Approximately $4.3 million (before underwriting discounts and commissions).
- Total Shares Sold in Offering: 8,816,339 ordinary shares (including the additional shares).
- Underwriters: SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change reported is the increase in outstanding ordinary shares and the influx of gross proceeds from the exercise of the underwriters' option. This transaction was executed under an Underwriting Agreement dated March 11, 2020, and pursuant to Registration Statement No. 333-233001.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or contingencies beyond the description of the share issuance mechanics.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and commissions.
- Confirm the total number of outstanding shares post-transaction.
- Review the original Underwriting Agreement dated March 11, 2020, for terms regarding the option exercise.
- Check subsequent filings for the intended use of the $4.3 million in gross proceeds.